Program with Questions

Program times are listed in AEST. To convert program times to your timezone, CLICK HERE 

[printfriendly]

Saturday 28th August                       Sponsored by

1200 – 1230 LUNCH & EXHIBITION
1230 – 1300 Welcome – Professor Neil Boudville

Acknowledgement of Country & Māori Welcome

1300 – 1500 SESSION ONE: Workforce and Research Advisory Committee
  Chairs: Professor Martin Gallagher, Associate Professor Jaquelyne Hughes
Indigenous health equity – it’s everyone’s business
Dr Jade TamateaQuestions:
In your service currently, is there a clinician or allied professional whose portfolio/responsibility includes ensuring equity is considered in clinical governance issues?
a. Yes
b. No, If not what do you see is the biggest barrier to having an ‘equity lead’ within the nephrology/medicine service?
a. Lack of formal FTE/funding for this role
b. Not relevant to the current service
c. There already exists another person/group responsible for this
d. Lack of specific expertise
e. Other [Answer in discussion forum]In your organisation are there available courses specifically teaching cultural safety to clinicians/allied health professionals such as yourself
a. Yes
b. NoIf not do you believe this would be of benefit to you and/or your service to run a specific course?
a. Yes
b. No
Aboriginal and Torres Strait Islander Peoples: Growing the nephrology workforce
Dr Karen NichollsQuestions:
My review of practise (in your usual occupation as a member of specialist nephrology workforce- be that clinician, policy leader or as a scientist), routinely references cultural safety
a. Yes
b. No My routine work practice includes reference to cultural safety, which I can show evidence of, if RACP includes in annual CPD returns
a. Yes
b. NoAnnual work performance reviews in my department ask about ways to improve cultural safety in the workplace
a. Yes
b. NoI incorporate cultural safety in the work plans and review cycles in my supervision of registrar and junior doctors
a. Yes
b. NoI support ANZSN developing a Cultural Safety Framework discussion paper for ANZSN consultation?
a. Yes
b. No
The Consider Statement – Consolidated criteria for strengthening reporting of health research involving Indigenous Peoples
Ms Tania HuriaQuestions:
The Consider Framework recommends strength based reporting of research with reference to values of First Nations peoples across Australia Aotearoa New Zealand and Canada. I support ANZSN community adopting consider statement to frame cultural safety and cultural strength in reporting of renal data in Australia and New Zealand.
a. Yes
b. No
KHA/RAC project
Professor Carmel Hawley
1500 – 1530 AFTERNOON TEA & EXHIBITION
1530 – 1715 SESSION TWO: Transplantation
  Chairs: Professor Toby Coates, Professor Karen Dwyer
Transplant Working Group Report
Dr Jeff WongQuestions:
Should COVID-19 vaccination be compulsory for access to the deceased donor list?
a. Yes
b. NoShould acute transplant experience remain a core component of Nephrology advanced training?
a. Yes
b. No
Equity and transplant waiting list dynamics in Australia
Angela Webster and Prof John KanellisQuestions:
Should we be formally consenting patients using a nationally unified approach to go on the waiting list as is done in Qld and VIC?
a. Yes
b. NoAre we as clinicians adequately counselling patients regarding the time to be activated, subsequent time and trajectory on the transplant list?
a. Yes
b. NoShould we have an additional opt in or opt out process (either as a subsection of the same consent form or separately) for willingness to accept high KDPI kidneys (eg. KDPI >90)?
a. Yes
b. NoShould patients be told any details regarding the ‘quality’ of the kidney they are receiving – e.g. approximate age or potentially relevant medical details (DM, smoking, IV drug use)?
a. Yes
b. No
Closing the gap: kidney transplantation for Māori and Pasifika peoples
Dr Andy Salmon and Professor Stephen McDonaldQuestions:
For many years, New Zealand has allowed live kidney donation from Māori and Pasifika peoples. Should Australia adopt this practice to allow living kidney donors from family members of First Nations Peoples to be considered?
a. Yes
b. NoIf ‘No’ why?
[Answer in discussion forum]How do you want ANZSN to support equitable access to living kidney donation for all families in Australia and Aotearoa New Zealand?
[Answer in discussion forum]What information would you like to know from the National Indigenous Kidney Transplant Taskforce about activities to improve access to kidney transplantation and outcomes of kidney transplantation for Aboriginal and Torres Strait Islander Peoples?
[Answer in discussion forum]

Sunday 29th August                     Sponsored by

1200 – 1330 SESSION THREE: Dialysis
  Chairs: Dr Geoff Kirkland, Martine Allars
Driving Rules
Dr Natasha CookQuestions:
Do you believe that some patients on haemodialysis pose a driving risk?
a. Yes
b. NoIf ‘Yes’ should this be recognised by licensing authorities?
a. Yes
b. NoDo you believe that some patients on peritoneal dialysis pose a driving risk?
a. Yes
b. NoIf ‘Yes’ should this recognised by licensing authorities?
a. Yes
b. NoHave you ever been asked to give an opinion regarding driving fitness of a patient?
a. Yes
b. NoAre you satisfied with the transport options available to your patients who are not fit to drive themselves to or from dialysis sessions?
a. Yes
b. No
Rare Events on Dialysis
Professor Matthew JoseQuestons:
If your unit had a rare adverse event, you (tick all that apply):
a. would most likely put together a scientific paper and publish your learnings
b. would report it to your own hospital safety system
c. would report it to a statewide /regional safety system
d. would report it to a national safety systemThe ANZSN is developing an end to end process to capture learnings from rare adverse events. Which mode of dissemination would you find beneficial
a. Webinar update
b. Updates on ANZSN website
c. Regular review in ANZSN e-news
d. All of the above
e. Other [Answer in discussion forum]
Addressing the Environmental Impact of Dialysis
A/Prof Katherine BarracloughQuestions:
Which of the following initiatives is likely to be most useful to your unit?
a. Developing a dialysis unit Green Star Program
b. Developing guidelines for optimal waste management in dialysis units
c. Developing guidelines for reverse osmosis rejection water recycling
d. Other [Answer in discussion forum]Which form of recognition do you think would be most useful in encouraging dialysis unit participation in a Green Star Program?
a. Recognition of individual efforts through acknowledgement on websites/at conferences
b. Recognition of individual efforts through prizes/vouchers
c. Recognition of unit efforts through acknowledgement on websites/at conferences
d. Recognition of unit efforts through prizes/vouchers
1330 – 1400 LUNCH & EXHIBITION
1400 – 1530 SESSION FOUR: Supportive Care and Implementation
  Chairs: Dr Scott Crawford, Dr Amanda Mather
Kidney Supportive Care: ways to develop and integrate care in Australia and New Zealand
Dr Kathryn DucharletQuestions:
Would it be helpful in your experience to have a (ANZSN endorsed) clear consensus definition of Kidney /Renal Supportive Care? (including core components?)
a. Yes
b. No
c. UncertainTo improve consistency of information and illness expectations for clinicians, patients and families regarding prognosis and treatment decision making, would you support routine observational data collection for people with ESKD managed conservatively?
a. Yes
b. No
c. I don’t knowIf yes, who would be best situated? [Answer in Discussion Forum]In the Renal Unit where you primarily practice, is there a system of internal data collection for:
a. Conservative Care patients only (Yes/No/Uncertain)
b. Any patients attending the Renal / Kidney Supportive Care Service only
(Yes / No / Uncertain)
c. Both CC and RSC
(Yes/No/Uncertain)If your Renal Unit had adequate resources, would you support a pilot registry for routine data collection on all patients known to a Nephrologist with ESKD (eGFR<15) managed conservatively in Australia and New Zealand?
a. Yes
b. No
c. UncertainIf your Renal Unit had adequate resources, would you support a pilot registry of routine data collection for all patients known to your unit’s Renal/Kidney Supportive Care service?
a. Yes
b. No
c. UncertainWhat metrics would be most useful from your perspective?
a. Demographic and basic clinical outcome data (similar to ANZDATA (e.g. patient characteristics, comorbidities, timing of Nephrology referral, renal function, mortality, end of life care characteristics and healthcare utilisation)
b. Patient reported outcome data (e.g. symptom scores, quality of life scores, carer burden measures, functional status measures)
c. A combination of these measures
d. None of these
Perioperative Shared Decision Making in the Bay of Plenty
Dr Heidi OmundsenQuestions:
As your hospital/service currently stands, do you have a shared decision making clinic for patients with complex surgical decisions (not necessarily simply high risk patients)
a. Yes
b. NoIf not what is the biggest barrier to setting up such a service?
[Insert one word or short phrase in
Discussion Forum]From what you have learned about the Serious Illness Conversation guide today, do you see this initiative/program being employed by nephrologists or clinical nurse specialists within the renal space?
a. Yes
b. NoIf ‘No’ to Q4.9 what is the biggest barrier you identify to employing a structured conversation guide?
a. Lack of time
b. Comfort with using a script
c. Not relevant to renal service shared goals/advanced care planning
d. Lack of way to document the outcome
e. Other [Answer in Discussion Forum]
Research to Practice- Implementation Strategies and Challenges
A/Prof Rathika KrishnasamyQuestions:
Who should be responsible for advocating new therapies (ie SGLT2-i) for CKD patients in ANZ (tick all that apply)?
a. Primary care physicians
b. Physicians (incl nephrologists)
c. Consumer or consumer groups
d. CARI guidelines
e. Industry
f. ANZSNHow to measure a successful implementation strategy?
a. Primary Care Record Audit
b. MBS/PBS/Pharmac data linkage
c. Clinician survey
d. Consumer survey
e. Hospital audits
f. Set QI
g. Too hard to doHow should the society better support clinicians and consumers to implement new evidence
a. Education programs –online, ASM
b. Guidelines/Policies
c. GP education handbook
d. Others (word cloud
1530 – 1600 AFTERNOON TEA & EXHIBITION
1600 – 1700 SESSION FIVE: Data supported practice
  Chairs: A/Prof Peter Mount, Michael Papesch
New Quality Indicator Report
Dr Nicholas GrayQuestions:
The ANZDATA quality indicator report with unit identifiable data should be distributed to (tick all that apply):
a. Nephrology Heads of Department (HOD) and Health Service CEOs (current state)
b. ANZSN (Policy and Quality Committee)
c. Government departments of health with governance oversight of these health services
d. Make publicly available, in an appropriate format
e. Other [Answer in discussion forum]Should ANZSN organise an annual meeting to discuss the results of the ANZSN/ANZDATA quality indicator report?
a. Yes: as a standalone virtual meeting
b. Yes: a face-to-face session as part of the Annual Scientific Meeting
c. No – not necessaryIf there is an annual meeting to discuss the results of the ANZSN/ANZDATA quality indicator report, who should be invited (tick all that apply)?
a. Nephrology Heads of Department (or their delegate)
b. A key RSA member from each unit
c. All ANZSN members
d. Renal nurse practitioners
e. Consumer representatives
f. Payer and policy maker (i.e. government) representatives
Quality Indicator Implementation
A/Prof Nigel ToussaintQuestions:
Reporting on which of the following planned or potential ANZSN/ANZDATA quality indicators do you believe significantly improves the lives of people with kidney disease (select all that apply):
a. Access to kidney transplantation
b. Bloodstream infections in haemodialysis patients
c. Consumer engagement
d. Graft survival
e. Patient-reported outcome and/or experience measures
f. Peritonitis rates
g. Permanent access at first dialysis
h. Mortality
i. Other [Answer in discussion forum]What do you think should be the highest quality improvement priority for the ANZSN including, but not limited to, the options already presented?
[insert single word or short phrase in the discussion forum]Formal data collection of bloodstream infections in haemodialysis patients in Australia and Aotearoa New Zealand should be established as a key ANZSN/ANZDATA quality indicator?
a. Yes, this is an important quality indicator and data should be collected and reported through ANZDATA
b. Yes, this is an important quality indicator and data should be collected and reported through any web-based portal
c. Yes-by exploring data linkage on existing collection
d. No, collecting this data would not improve outcomesWhen a unit is observed in an ANZDATA quality indicator report as a positive outlier what should happen?
a. ANZSN and/or ANZDATA should have a process for highlighting examples and drivers of excellence, and sharing this information with other units and ANZSN members
b. No formal action is required: individual units may enquire into excellent or outstanding practice as they see fit
Approaches to ANZSN Quality Indicator outliers
Dr Emily SeeQuestions:
Who of the following has responsibility to take action when a unit is observed in an ANZDATA quality indicator report as a negative outlier (tick all that apply)
a. The nephrology Head of Department for that health service
b. ANZSN
c. The CEO, executive and board for that health service
d. All members of the renal health care team in that health service
e. The government health department with oversight of this health serviceIf units are consistently identified in ANZDATA quality indicators reports as negative outliers what should happen (tick all that apply)?
a. Follow up actions internally by that health service
b. Follow up by relevant government department
c. ANZSN should support or advise this service to help them improve
d. ANZSN should advocate with relevant government departments on the need for improvement
e. No action is required
1700 – 1730 Policy Polls Review and Close
Chair: A/Prof Peter Mount